Quinine dosage may not need to be reduced during continuous venovenous hemodiafiltration in severe anuric malaria [1]

Clinical Infectious Diseases

Volumn 39, Issue 2, 2004, Pages 288-289

  Jacobs, F ^a   Nicolaos, G ^b   Prieur, S ^a   Brivet, F ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

QUININE;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LETTER; LIVER METABOLISM; MALARIA; MALE; PRIORITY JOURNAL; SPECTROFLUOROMETRY;

AGED; ANTIMALARIALS; ANURIA; HEMODIAFILTRATION; HUMANS; MALARIA; MALE; QUININE;

EID: 3242806605     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421782     Document Type: Letter

References (3)

1. Sabto JK, Pierce RM, West RH, Gurr FW. Hemodialysis, peritoneal dialysis, plasmapheresis and forced diuresis for the treatment of quinine overdose. Clin Nephrol 1981; 16:264-8.
2. Davies JG, Greenwood EF, Kingswood JC, Sharpstone P, Street MK. Quinine clearance in continuous venovenous hemofiltration. Ann Pharmacother 1996; 30:487-90.
3. Franke U, Proksch B, Muller M, Risler T, Ehninger G. Drug monitoring of quinine by HPLC in cerebral malaria with acute renal failure treated by haemofiltration. Eur J Clin Pharmacol 1987; 33:293-6.